BMJ, 2012, DOI: 10.1136/bmj.e4348
5 Pages Posted: 10 May 2013 Last revised: 19 Jun 2013
Date Written: August 7, 2012
Data indicate that the widely touted “innovation crisis” in pharmaceuticals is a myth. The real innovation crisis, say Donald Light and Joel Lexchin, stems from current incentives that reward companies for developing large numbers of new drugs with few clinical advantages over existing ones.
Keywords: pharmaceuticals, pharmaceutical policy, regulation, innovation crisis
Suggested Citation: Suggested Citation
Light, Donald W. and Lexchin, Joel, Pharmaceutical Research and Development: What Do We Get for All that Money? (August 7, 2012). BMJ, 2012, DOI: 10.1136/bmj.e4348. Available at SSRN: https://ssrn.com/abstract=2262843 or http://dx.doi.org/10.2139/ssrn.2262843